Status:

RECRUITING

Impact of the Novel UC-TREAT Diet on the Gut Microbiome and Its Acceptability in Healthy Adults and Adults With Quiescent Ulcerative Colitis

Lead Sponsor:

University of Glasgow

Conditions:

Ulcerative Colitis (UC)

Eligibility:

All Genders

16+ years

Phase:

NA

Brief Summary

This will be an open-label dietary intervention study recruiting both healthy adults (≥16y) and adults with quiescent Ulcerative Colitis (UC). The study will span a total of 25 days and is divided int...

Detailed Description

This will be an open-label dietary intervention study recruiting both healthy adults (≥16y) and adults with quiescent Ulcerative Colitis (UC) . The study will span a total of 25 days and is divided in...

Eligibility Criteria

Inclusion

  • Individuals with Ulcerative Colitis:
  • Confirmed diagnosis of Ulcerative Colitis
  • ≥16 years of age
  • Motivated to follow the prescribed diet for the study period
  • Healthy controls:
  • ≥16 years of age
  • Motivated to follow the prescribed diet for the study period

Exclusion

  • Individuals with Ulcerative Colitis:
  • Self-reported active disease (SCCAI≥5) and/or a score ≥2 on any variable within SCCAI
  • Previous surgery related to their UC (e.g. colectomy)
  • Adjustment of medication dose in the previous month
  • Initiation of a new medication in the prior 3 months
  • BMI≥35kg/m2
  • Pregnancy or lactation
  • Regular use of pre/probiotic supplements
  • Antibiotics or steroid use in the past 2 months
  • Weight fluctuations ≥ 2kg in the past month
  • Dietary restrictions (vegetarian, vegan, gluten-free etc)
  • Participation in other interventional research.
  • Healthy controls:
  • Regular use of medication or regular visits to a physician
  • History of gut surgery
  • BMI≥35kg/m2
  • Pregnancy or lactation
  • Regular use of pre/probiotic supplements
  • Antibiotics or steroid use in the past 2 months
  • Weight fluctuations ≥ 2kg in the past month
  • Dietary restrictions (vegetarian, vegan, gluten-free etc)
  • Participation in other interventional research.

Key Trial Info

Start Date :

May 8 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2026

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT06998277

Start Date

May 8 2024

End Date

December 30 2026

Last Update

June 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Glasgow

Glasgow, United Kingdom, G31 2ER